Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice
- 1 November 2005
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 7 (s1), S19-S23
- https://doi.org/10.1111/j.1463-1326.2005.00529.x
Abstract
The attainment and maintenance of good glycaemic control in both type 1 and type 2 diabetes are major challenges. The main (perceived) barriers of therapy are poor compliance with prescribed medication, hypoglycaemia, fear of insulin injection and fear of self-testing by finger pricking. Another major issue is the acceptance and uptake of new insulin-delivery systems and routes of administration. Insulin therapy regimens and insulin preparations are nowadays often chosen because of the ease of delivery. The use of inhaled insulin may, because of the relative ease of administration, facilitate the transfer of type 2 diabetes patients from tablets to insulin, especially in patients with fear or phobia of needles. However, non-injectable insulin will not automatically be preferred to subcutaneous (SC) insulin injections and a proper assessment of patient acceptance and preference is of great importance. Recent studies suggest that patients may prefer inhaled insulin (ExuberKeywords
This publication has 20 references indexed in Scilit:
- Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacyDiabetes, Obesity and Metabolism, 2005
- Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic SubjectsDiabetes Care, 2005
- Availability of Inhaled Insulin Promotes Greater Perceived Acceptance of Insulin Therapy in Patients With Type 2 DiabetesDiabetes Care, 2005
- Preference for insulin delivery systems among current insulin users and nonusersClinical Therapeutics, 2004
- Clinical Pharmacokinetics and Pharmacodynamics of Inhaled InsulinClinical Pharmacokinetics, 2004
- Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic SubjectsDiabetes Care, 2003
- When oral agents fail: practical barriers to starting insulinInternational Journal of Obesity, 2002
- Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995